Entia Biosciences, Inc.
ERGO
$0.0001
-$0.0001-50.00%
| 12/31/2016 | 09/30/2016 | ||||
|---|---|---|---|---|---|
| Revenue | 9.79% | -57.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.79% | -57.42% | |||
| Cost of Revenue | -24.63% | -62.36% | |||
| Gross Profit | 26.41% | -54.78% | |||
| SG&A Expenses | 23.95% | -15.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.87% | -19.44% | |||
| Operating Income | -23.69% | 6.51% | |||
| Income Before Tax | -49.86% | 28.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -49.86% | 28.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -49.86% | 28.09% | |||
| EBIT | -23.69% | 6.51% | |||
| EBITDA | -24.61% | 6.65% | |||
| EPS Basic | -49.51% | 27.97% | |||
| Normalized Basic EPS | -32.81% | 7.25% | |||
| EPS Diluted | -49.51% | 27.97% | |||
| Normalized Diluted EPS | -32.81% | 7.25% | |||
| Average Basic Shares Outstanding | 0.01% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
